Hospital
Titus County Hospital District
Titus County Hospital District was paid $6.72M by Medicaid between Aug 2020 and Dec 2024, across 87 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 32% of everything it billed.
33Billing provider infoTITUS COUNTY HOSPITAL DISTRICT
MT PLEASANT, TX 75455
MT PLEASANT, TX 75455
33aNPI1174526529assigned 05/31/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.72M
24GClaims88,178
24DCodes billed87
24AFirst – last monthAug 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#25 of 109
Median peer was paid$1.15M
This provider vs. median5.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,119 | $110K | |
| 2021 | 24,108 | $1.06M | |
| 2022 | 26,898 | $2.12M | |
| 2023 | 22,979 | $2.29M | |
| 2024incomplete | 11,074 | $1.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 32% | 2,705 | 2,606 | $2.17M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 5,396 | 4,999 | $1.39M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 8,423 | 8,041 | $995K |
| 41899 | Unlisted procedure, dentoalveolar structures | 6.4% | 452 | 438 | $429K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5.1% | 2,312 | 676 | $343K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.8% | 789 | 731 | $188K |
| 71045 | Radiologic examination, chest; single view | 2.0% | 2,003 | 1,857 | $132K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 3,201 | 2,503 | $125K |
| 80053 | Comprehensive metabolic panel | 1.4% | 9,301 | 8,543 | $93K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 587 | 556 | $91K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 3,079 | 2,560 | $85K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 2,405 | 2,196 | $85K |
75 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,642 | $58K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,027 | $57K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,686 | $56K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 530 | $49K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,666 | $46K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 257 | $41K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 277 | $26K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 160 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,081 | $24K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 983 | $23K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 303 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,072 | $16K |
| 36592 | <1% | 1,085 | $11K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 366 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 653 | $10K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 45 | $10K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 45 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 255 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 263 | $8K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 39 | $7K |
| 84439 | <1% | 906 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,149 | $7K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 89 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 202 | $6K |
| 87420 | <1% | 251 | $5K | |
| 85027 | <1% | 553 | $5K | |
| 80061 | Lipid panel | <1% | 1,244 | $5K |
| 81001 | <1% | 2,016 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 77 | $4K |
| 81003 | <1% | 2,083 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $3K |
| 85007 | <1% | 748 | $3K | |
| 84484 | <1% | 738 | $3K | |
| 81025 | <1% | 229 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 224 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 49 | $3K |
| 83880 | <1% | 396 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 486 | $2K |
| 87088 | <1% | 672 | $1K | |
| 83735 | <1% | 626 | $988.57 | |
| 83690 | <1% | 172 | $986.24 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $844.77 |
| 87430 | <1% | 48 | $835.03 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 28 | $827.92 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 384 | $703.23 |
| 86140 | <1% | 113 | $617.18 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 232 | $612.42 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 37 | $603.35 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 153 | $587.73 |
| 87186 | <1% | 357 | $529.91 | |
| 87077 | <1% | 363 | $483.65 | |
| 85610 | <1% | 863 | $441.32 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16 | $416.02 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 25 | $402.98 |
| 83605 | <1% | 132 | $350.05 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 41 | $303.54 |
| 84481 | <1% | 14 | $201.62 | |
| 94761 | <1% | 19 | $184.53 | |
| 82803 | <1% | 12 | $154.66 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 229 | $152.14 |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,765 | $111.66 |
| 82330 | <1% | 12 | $88.19 | |
| 82728 | <1% | 13 | $62.19 | |
| 85652 | <1% | 16 | $43.77 | |
| 82570 | <1% | 58 | $21.37 | |
| 86592 | <1% | 16 | $17.05 | |
| 82043 | <1% | 41 | $13.86 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16 | $8.64 |
| 84295 | <1% | 12 | $3.84 | |
| 84132 | <1% | 14 | $3.80 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17 | $3.64 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 18 | $1.21 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 36 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 31 | $0.00 |
| 36416 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOECKMANN, PATTY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Titus County Hospital District | Mount Pleasant, TX | $1.63M |
| Titus County Hospital District | Mount Pleasant, TX | $510K |
| Titus County Hospital District | Mount Pleasant, TX | $63K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.